Concise Review: Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

The development of mesenchymal stem cells (MSCs) as cell‐based drug delivery vectors for numerous clinical indications, including cancer, has significant promise. However, a considerable challenge for effective translation of these approaches is the limited tumor tropism and broad biodistribution ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Krueger, Timothy E. G., Thorek, Daniel L. J., Denmeade, Samuel R., Isaacs, John T., Brennen, W. Nathaniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127224/
https://www.ncbi.nlm.nih.gov/pubmed/30070053
http://dx.doi.org/10.1002/sctm.18-0024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127224/
https://www.ncbi.nlm.nih.gov/pubmed/30070053
http://dx.doi.org/10.1002/sctm.18-0024

Ejemplares similares